LEADER 02190cam 2200193 a 4500
001 988496
005 20191125092822.0
008 191129r20192018nyu g bv 001 0 eng d
010 $a2018000263
020 $a9781524711481 (pbk.) :$cNT$455
040 $aTWTNM$beng$dTWTNM
050 00$aHD9995.H423$bU627 2018
082 04$a338.7681761$222
100 1 $aCarreyrou, John.
245 10$aBad blood :$bsecrets and lies in a Silicon Valley startup /$cJohn Carreyrou.
246 30$aSecrets and lies in a Silicon Valley startup.
260 $aNew York :$bAlfred A. Knopf,$c2019, c2018.
300 $ax, 339 p. ;$c24 cm.
504 $aIncludes bibliographical references (p. 305-324) and index.
505 0 $aA purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- Who is LTC Shoemaker? -- Lighting a Fuisz -- Ian Gibbons -- Chiat\ Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue.
520 $aIn 2015, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup unicorn promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at 9billion, putting Holmes's worth at an estimated billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When John Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold- rush frenzy of Silicon Valley.--Publisher's description.
600 10$aHolmes, Elizabeth,$d1984-.
650 0$aHematologic equipment industry$zUnited States.
650 0$aNew business enterprises$xCorrupt practices$zUnited States$vCases.
650 0$aSecurities fraud$zUnited States$vCases.